Production (Stage)
Avenue Therapeutics, Inc.
ATXI
$0.2088
-$0.0113-5.13%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.61% | -12.29% | 9.33% | 49.56% | 12.71% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,258.62% | 101.23% | 68.13% | -149.03% | 99.00% |
| Change in Net Operating Assets | 107.55% | 161.72% | -155.69% | -155.56% | -197.53% |
| Cash from Operations | 35.52% | 4.50% | 6.29% | 21.67% | -51.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 50.00% | -- |
| Cash from Investing | -- | -- | 100.00% | 50.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -13.12% | 46.74% | -7.44% | -4.10% | -36.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -73.08% | -- | -2,466.67% | -- | -- |
| Cash from Financing | -17.37% | 30.71% | -8.55% | -5.19% | -34.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.11% | 116.47% | 4,450.00% | 391.63% | -178.74% |